Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP646022.RAnUinOpimp4ee9C4TVZSo6Ulmlxqs1LoYDszwilCP6jU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP646022.RAnUinOpimp4ee9C4TVZSo6Ulmlxqs1LoYDszwilCP6jU130_assertion type Assertion NP646022.RAnUinOpimp4ee9C4TVZSo6Ulmlxqs1LoYDszwilCP6jU130_head.
- NP646022.RAnUinOpimp4ee9C4TVZSo6Ulmlxqs1LoYDszwilCP6jU130_assertion description "[In addition, we showed that down-regulation of ERK2 or MKP-1 decreases the basal level of Bcl-2 protein and that inhibition of Bcl-2 activity sensitizes ovarian cancer cells to cisplatin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646022.RAnUinOpimp4ee9C4TVZSo6Ulmlxqs1LoYDszwilCP6jU130_provenance.
- NP646022.RAnUinOpimp4ee9C4TVZSo6Ulmlxqs1LoYDszwilCP6jU130_assertion evidence source_evidence_literature NP646022.RAnUinOpimp4ee9C4TVZSo6Ulmlxqs1LoYDszwilCP6jU130_provenance.
- NP646022.RAnUinOpimp4ee9C4TVZSo6Ulmlxqs1LoYDszwilCP6jU130_assertion SIO_000772 18089824 NP646022.RAnUinOpimp4ee9C4TVZSo6Ulmlxqs1LoYDszwilCP6jU130_provenance.
- NP646022.RAnUinOpimp4ee9C4TVZSo6Ulmlxqs1LoYDszwilCP6jU130_assertion wasDerivedFrom befree-2016 NP646022.RAnUinOpimp4ee9C4TVZSo6Ulmlxqs1LoYDszwilCP6jU130_provenance.
- NP646022.RAnUinOpimp4ee9C4TVZSo6Ulmlxqs1LoYDszwilCP6jU130_assertion wasGeneratedBy ECO_0000203 NP646022.RAnUinOpimp4ee9C4TVZSo6Ulmlxqs1LoYDszwilCP6jU130_provenance.